Mediplantex National Pharmaceutical JSC (HNX:MED)

HNX:MED Revenue

Mediplantex National Pharmaceutical JSC had revenue of 86.90B VND in the quarter ending June 30, 2025, a decrease of -37.94%. This brings the company's revenue in the last twelve months to 360.49B, down -22.34% year-over-year. In the year 2024, Mediplantex National Pharmaceutical JSC had annual revenue of 443.14B with 10.03% growth.

• Revenue (ttm): 360.49B
• Revenue Growth: -22.34%
• P/S Ratio: 0.78
• Revenue / Employee: 1.10B
• Employees: 328
• Market Cap: 282.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	443.14B	40.39B	10.03%
Jan 1, 2024	402.74B	1.69B	0.42%
Dec 31, 2022	401.05B	57.10B	16.60%
Dec 31, 2021	343.95B	-177.44B	-34.03%
Dec 31, 2020	521.39B	-207.08B	-28.43%